The provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry has been awarded a contract by Bicycle Therapeutics plc (Nasdaq: BCYC). The project will focus on the mathematical computer modelling of interactions between tumour and Bicycle® compounds in an immune-oncology setting. This will be the fourth project conducted by Physiomics in the immune-oncology space and highlights the Company's rapidly developing capabilities in thi
01 Jul 2019
Traction building in immune-oncology
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Traction building in immune-oncology
Physiomics Plc (PYC:LON) | 1.3 0 0.0% | Mkt Cap: 1.76m
- Published:
01 Jul 2019 -
Author:
Derren Nathan -
Pages:
6
The provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry has been awarded a contract by Bicycle Therapeutics plc (Nasdaq: BCYC). The project will focus on the mathematical computer modelling of interactions between tumour and Bicycle® compounds in an immune-oncology setting. This will be the fourth project conducted by Physiomics in the immune-oncology space and highlights the Company's rapidly developing capabilities in thi